Swiss distribution group DKSH reported a 6.7% increase in underlying profit for 2025, with Core EBIT rising to 349 million Swiss francs from 343.1 million francs in 2024. The company's healthcare unit led growth with a 4.6% sales increase at constant rates to 5.82 billion francs and a 7.5% rise in Core EBIT to 174.2 million francs.

Despite the underlying profit gains, reported net income fell 4.5% to 210.9 million francs as the stronger Swiss franc eroded Asia Pacific revenues. Net sales remained broadly flat at 11.07 billion francs, declining 0.2% in Swiss franc terms but growing 2.9% on a constant-exchange-rate basis. Foreign exchange movements reduced net sales by 3.1 percentage points.

The company's operational momentum strengthened in the second half of 2025, with net sales rising 3.6% at constant rates and Core EBIT expanding 8.1% compared to 1.7% and 5.2% respectively in the first half. CEO Stefan P. Butz noted the group delivered "growth, increased margins, and high cash generation in a muted market environment" and expects Core EBIT to exceed 2025 levels in 2026.